Currents in Contemporary Ethics

Author:

Harrell Heather

Abstract

The Human Papillomavirus (HPV) vaccine burst onto the market and the legislative scene nearly simultaneously. Marketed as an amazing medical breakthrough, the vaccine GARDASIL prevents infection with four strains of Human Papillomavirus in nave populations; these four strains are responsible for 70% of cervical cancers and 90% of genital warts. Although most agreed that the vaccine was a wonderful medical advancement with the potential to save women's lives, there was strong disagreement about and a vocal public response to legislative attempts to require girls to receive HPV vaccines for school attendance.The strong public response to HPV vaccine mandates partially stemmed from the sense that this vaccine is different from previously mandated vaccines because it attempts to prevent disease whose sole route of transmission is through sexual contact. Most other diseases covered by mandated vaccines are spread through the air, with little an individual can do in altering their behavior to prevent infection.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Reference35 articles.

1. 2. Wikipedia, , s.v. “Gardasil,” available at (last visited January 8, 2009).

2. 20. See, e.g., Va. Code Ann. § 32.1–46 (A) (12) and (B) (3) (2007). Virginia was the only state to pass a mandate though many other states considered them. See Gerber, , supra note 4, at 495. The vaccine is only approved for use in females in the United States; however, the fact that only women would be mandated to be protected from HPV while males would not is important regardless of FDA approval.

3. 35. See Ravin v. State, 537 P.2d 494, 502 (Alaska 1975) (stating that “‘Big Brother’ cannot, in the name of public health, dictate to anyone what he can eat or drink or smoke in the privacy of his own home.”).

4. 12. National Cancer Institute, U.S. National Institutes of Health, “Cervical Cancer Prevention,” available at (last visited January 8, 2009).

5. 26. See supra note 19.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3